National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis

Launched by CENTRE HOSPITALIER INTERCOMMUNAL CRETEIL · Apr 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a condition called parietal endometriosis, which occurs when endometrial tissue grows outside the uterus and affects the abdominal wall. The research aims to evaluate different treatment options, including surgery and a technique called cryoablation, which uses extreme cold to target and destroy unwanted tissue. The study is being conducted by a team of specialists and is currently looking for female participants aged 18 and older who have symptoms related to parietal endometriosis, such as pain or bleeding that affects their quality of life.

To be eligible for this trial, participants must have signs of parietal endometriosis confirmed by imaging tests like MRI or ultrasound and must be experiencing bothersome symptoms. However, certain individuals may not qualify, including those under 18, pregnant women, or those with specific health issues that could interfere with the study. If you join the trial, you can expect to receive thorough medical care and monitoring throughout the process. This study is important as it aims to improve treatment options and outcomes for women suffering from this condition.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Presence of parietal endometriosis: with suggestive clinical and imaging criteria (MRI and ultrasound)
• • Symptomatic parietal endometriosis (VAS \> 3 OR bothersome bleeding OR reported impact on quality of life)
• Exclusion Criteria:
• • Endometriosis not affecting the anterior wall of the abdomen (as deep pelvic muscle: ilio-psoas, obturators, perineal, ischio-anal fossa)
• • Minor patient (\< 18 years)
• • Pregnant patient at any trimester
• • Patient with hemostasis disorders (constitutional or acquired)
• • Patient with systemic infection or localized scar infection upon inclusion.
• • Patient with contraindications to MRI
• • Female patient with a planned medical or surgical procedure for the duration of the study that may interfere with the proper conduct of the study.
• • Patient unable to understand the information provided
• • Patient who is not affiliated to the social security system
• • Patient under curatorship or tutorship
• • Patient with a nodule of primary or secondary malignant tumor origin